A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance. Yang H, Bae SH, Nam H, Lee HL, et al. J Hepatol 2022 Apr 7. pii: S0168-8278(22)00208.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang H, Bae SH, Nam H, Lee HL, et al. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol 2022 Apr 7. pii: S0168-8278(22)00208.
PMID: 35398462